Publication: First evidence of a pro-inflammatory response to severe infection with influenza virus H1N1
| dc.contributor.author | Fernández de Castro, Isabel | |
| dc.contributor.author | Guzman-Fulgencio, Maria | |
| dc.contributor.author | Garcia-Alvarez, Monica | |
| dc.contributor.author | Resino, Salvador | |
| dc.contributor.funder | Instituto de Salud Carlos III | |
| dc.date.accessioned | 2019-05-21T08:54:55Z | |
| dc.date.available | 2019-05-21T08:54:55Z | |
| dc.date.issued | 2010 | |
| dc.description.abstract | The great majority of infections caused by the pandemic variant of the influenza virus (nvH1N1) are self-limited, but a small percentage of patients develop severe symptoms requiring hospitalization. Bermejo-Martin and colleagues have presented a pilot study describing the differences in the early immune response for patients both mildly and severely infected with nvH1N1. Patients who develop severe symptoms after nvH1N1 infection showed Th1 and Th17 'hypercytokinemia', compared to mildly infected patients and healthy controls. The mediators involved with the Th1 and Th17 profiles are known to be involved in antiviral, pro-inflammatory and autoimmune responses. This is the first work reporting the association of a pro-inflamatory immune response with a severe pandemic infection, although it is likely that more studies are needed to understand the detrimental or beneficial roles these cytokines play in the evolution of mild and severe nvH1N1 infection. | es_ES |
| dc.description.peerreviewed | Sí | es_ES |
| dc.description.sponsorship | This work was supported by grants from Instituto de Salud Carlos III (PI08/0738; UIPY 1467/07) to SR. MG-F is supported by a grant of Instituto de Salud Carlos III (CM09/00031). MG-A is supported by a grant of Instituto de Salud Carlos III (CM08/00101). | es_ES |
| dc.format.number | 1 | es_ES |
| dc.format.page | 115 | es_ES |
| dc.format.volume | 14 | es_ES |
| dc.identifier.citation | Crit Care. 2010;14(1):115. | es_ES |
| dc.identifier.doi | 10.1186/cc8846 | es_ES |
| dc.identifier.e-issn | 1466-609X | es_ES |
| dc.identifier.issn | 1364-8535 | es_ES |
| dc.identifier.journal | Critical care (London, England) | es_ES |
| dc.identifier.pubmedID | 20236480 | es_ES |
| dc.identifier.uri | http://hdl.handle.net/20.500.12105/7622 | |
| dc.language.iso | eng | es_ES |
| dc.publisher | BioMed Central (BMC) | es_ES |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/PI08/0738 | es_ES |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/UIPY1467/07 | es_ES |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/CM09/00031 | es_ES |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/CM08/00101 | es_ES |
| dc.relation.publisherversion | https://doi.org/10.1186/cc8846 | es_ES |
| dc.repisalud.centro | ISCIII::Centro Nacional de Microbiología | es_ES |
| dc.repisalud.institucion | ISCIII | es_ES |
| dc.rights.accessRights | open access | es_ES |
| dc.rights.license | Atribución-NoComercial-CompartirIgual 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/4.0/ | * |
| dc.subject.mesh | Case-Control Studies | es_ES |
| dc.subject.mesh | Cytokines | es_ES |
| dc.subject.mesh | Humans | es_ES |
| dc.subject.mesh | Inflammation | es_ES |
| dc.subject.mesh | Influenza A Virus, H1N1 Subtype | es_ES |
| dc.subject.mesh | Influenza, Human | es_ES |
| dc.title | First evidence of a pro-inflammatory response to severe infection with influenza virus H1N1 | es_ES |
| dc.type | journal article | es_ES |
| dc.type.hasVersion | VoR | es_ES |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | 946b9e38-f60e-4226-8735-78ceebc4111a | |
| relation.isAuthorOfPublication | 7b71e6d9-e421-4483-8961-fa252b845788 | |
| relation.isAuthorOfPublication | 89b17350-14e3-4dfd-b797-6ee6ca5363b8 | |
| relation.isAuthorOfPublication.latestForDiscovery | 946b9e38-f60e-4226-8735-78ceebc4111a |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- FirstEvidenceOfA_2010.pdf
- Size:
- 120.7 KB
- Format:
- Adobe Portable Document Format
- Description:


